Cargando…
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Menopausal hormone therapy (MHT) has been widely used for the clinical treatment of symptoms associated with menopause in women. However, the exact nature of the relationship between MHT and the increased risk of breast cancer has not been fully elucidated. The results of the Women’s Health Initiati...
Autores principales: | Deng, Yu, Jin, Hongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088189/ https://www.ncbi.nlm.nih.gov/pubmed/34779589 http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0344 |
Ejemplares similares
-
Progestogens in menopausal hormone therapy
por: Bińkowska, Małgorzata, et al.
Publicado: (2015) -
Menopausal hormone therapy and breast cancer risk: All progestogens are not the same
por: Lambrinoudaki, Irene
Publicado: (2020) -
Identification of Candidate Genes in Breast Cancer Induced by Estrogen Plus Progestogens Using Bioinformatic Analysis
por: Deng, Yu, et al.
Publicado: (2022) -
Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference
por: Stevenson, John C, et al.
Publicado: (2020) -
Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer
por: Gallez, Anne, et al.
Publicado: (2021)